Conclusion
In this article we suggest on the basis of today’s pharmacological and molecular knowledge, that by modulating the RAS system and the delicate ACE / ACE 2 Ang II balance in the best way and at the right times with common treatments such as ACE-i, ARB and direct renin inhibitors we can have important preventive and curative benefits to fight SARS-Cov-2.
MAIN STATEMENTS
I, the undersigned, Francesco Ferrara and any other author, declare that:
We have no conflict of interest; We have not received funding; There are no sensitive data and no patients were recruited for this study; The document does not conflict with ethical legislation.
Regards